FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

723523007: Olaratumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3424932011 Olaratumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3424933018 Olaratumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olaratumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Olaratumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing olaratumab Has active ingredient True Olaratumab Inferred relationship Existential restriction modifier 1
Product containing olaratumab in parenteral dose form (medicinal product form) Has active ingredient True Olaratumab Inferred relationship Existential restriction modifier 1
Olaratumab Has active ingredient True Olaratumab Inferred relationship Existential restriction modifier 1
Product containing only olaratumab in parenteral dose form (medicinal product form) Has active ingredient True Olaratumab Inferred relationship Existential restriction modifier 1
Olaratumab 190mg/19ml solution for infusion vials Has specific active ingredient True Olaratumab Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has specific active ingredient True Olaratumab Inferred relationship Existential restriction modifier
Olaratumab 190mg/19ml solution for infusion vials 1 vial Has specific active ingredient True Olaratumab Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient True Olaratumab Inferred relationship Existential restriction modifier
Lartruvo 500mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has specific active ingredient True Olaratumab Inferred relationship Existential restriction modifier
Olaratumab 500mg/50ml solution for infusion vials 1 vial Has specific active ingredient True Olaratumab Inferred relationship Existential restriction modifier
Olaratumab 500mg/50ml solution for infusion vials Has specific active ingredient True Olaratumab Inferred relationship Existential restriction modifier
Lartruvo 500mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has specific active ingredient True Olaratumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start